PortfoliosLab logoPortfoliosLab logo
ASM vs. TGTX
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

ASM vs. TGTX - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Avino Silver & Gold Mines Ltd. (ASM) and TG Therapeutics, Inc. (TGTX). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, ASM achieves a 2.90% return, which is significantly lower than TGTX's 66.12% return. Over the past 10 years, ASM has underperformed TGTX with an annualized return of 11.05%, while TGTX has yielded a comparatively higher 21.61% annualized return.


ASM

1D
6.86%
1M
-18.39%
YTD
2.90%
6M
7.58%
1Y
72.24%
3Y*
109.07%
5Y*
37.29%
10Y*
11.05%

TGTX

1D
3.06%
1M
16.11%
YTD
66.12%
6M
57.96%
1Y
32.51%
3Y*
21.69%
5Y*
5.57%
10Y*
21.61%
*Multi-year figures are annualized to reflect compound growth (CAGR)

ASM vs. TGTX - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
ASM
Avino Silver & Gold Mines Ltd.
2.90%604.88%68.13%-22.95%-21.01%-33.77%124.14%-4.92%-54.48%-2.19%
TGTX
TG Therapeutics, Inc.
66.12%-0.96%76.23%44.38%-37.74%-63.48%368.65%170.73%-50.00%76.34%

Correlation

The correlation between ASM and TGTX is 0.19, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.19

Correlation (3Y)
Calculated over the trailing 3-year period

0.13

Correlation (5Y)
Calculated over the trailing 5-year period

0.15

Correlation (10Y)
Calculated over the trailing 10-year period

0.12

Correlation (All Time)
Calculated using the full available price history since May 3, 2010

0.08

The correlation between ASM and TGTX shifts across timeframes, from 0.08 (all time) to 0.19 (1 year), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

ASM:

$1.11B

TGTX:

$7.93B

EPS

ASM:

$0.23

TGTX:

$2.87

PE Ratio

ASM:

28.13

TGTX:

17.23

PEG Ratio

ASM:

0.08

TGTX:

0.03

PS Ratio

ASM:

9.37

TGTX:

11.37

PB Ratio

ASM:

4.02

TGTX:

13.59

Total Revenue (TTM)

ASM:

$110.70M

TGTX:

$700.35M

Gross Profit (TTM)

ASM:

$59.09M

TGTX:

$581.54M

EBITDA (TTM)

ASM:

$55.20M

TGTX:

$156.88M

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

ASM vs. TGTX — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

ASM
ASM Risk / Return Rank: 6969
Overall Rank
ASM Sharpe Ratio Rank: 7171
Sharpe Ratio Rank
ASM Sortino Ratio Rank: 7070
Sortino Ratio Rank
ASM Omega Ratio Rank: 6868
Omega Ratio Rank
ASM Calmar Ratio Rank: 6969
Calmar Ratio Rank
ASM Martin Ratio Rank: 6868
Martin Ratio Rank

TGTX
TGTX Risk / Return Rank: 6363
Overall Rank
TGTX Sharpe Ratio Rank: 6565
Sharpe Ratio Rank
TGTX Sortino Ratio Rank: 6464
Sortino Ratio Rank
TGTX Omega Ratio Rank: 6363
Omega Ratio Rank
TGTX Calmar Ratio Rank: 6464
Calmar Ratio Rank
TGTX Martin Ratio Rank: 6161
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

ASM vs. TGTX - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Avino Silver & Gold Mines Ltd. (ASM) and TG Therapeutics, Inc. (TGTX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.


ASMTGTXDifference
Sharpe ratioReturn per unit of total volatility

+0.19

Sortino ratioReturn per unit of downside risk

+0.31

Omega ratioGain probability vs. loss probability

1.20

1.16

+0.03

Calmar ratioReturn relative to maximum drawdown

1.39

1.00

+0.39

Martin ratioReturn relative to average drawdown

2.95

1.81

+1.14

ASM vs. TGTX - Sharpe Ratio Comparison

The current ASM Sharpe Ratio is 0.89, which is comparable to the TGTX Sharpe Ratio of 0.69. The chart below compares the historical Sharpe Ratios of ASM and TGTX, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Drawdowns

ASM vs. TGTX - Drawdown Comparison

The maximum ASM drawdown since its inception was -94.10%, smaller than the maximum TGTX drawdown of -99.52%. Use the drawdown chart below to compare losses from any high point for ASM and TGTX.


Loading charts...

Drawdown Indicators


ASMTGTXDifference

Max Drawdown

Largest peak-to-trough decline

-94.10%

-99.52%

+5.42%

Max Drawdown (1Y)

Largest decline over 1 year

-52.40%

-32.66%

-19.74%

Max Drawdown (3Y)

Largest decline over 3 years

-52.40%

-75.42%

+23.02%

Max Drawdown (5Y)

Largest decline over 5 years

-68.51%

-90.75%

+22.24%

Max Drawdown (10Y)

Largest decline over 10 years

-90.91%

-93.19%

+2.28%

Current Drawdown

Current decline from peak

-43.15%

-78.79%

+35.64%

Average Drawdown

Average peak-to-trough decline

-63.76%

-91.43%

+27.67%

Ulcer Index

Depth and duration of drawdowns from previous peaks

24.57%

18.04%

+6.53%

Volatility

ASM vs. TGTX - Volatility Comparison

Avino Silver & Gold Mines Ltd. (ASM) has a higher volatility of 26.77% compared to TG Therapeutics, Inc. (TGTX) at 15.65%. This indicates that ASM's price experiences larger fluctuations and is considered to be riskier than TGTX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


ASMTGTXDifference

Volatility (1M)

Calculated over the trailing 1-month period

26.77%

15.65%

+11.12%

Volatility (6M)

Calculated over the trailing 6-month period

65.36%

34.28%

+31.08%

Volatility (1Y)

Calculated over the trailing 1-year period

82.16%

47.22%

+34.94%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

66.03%

87.77%

-21.74%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

69.72%

86.88%

-17.16%

Dividends

ASM vs. TGTX - Dividend Comparison

Neither ASM nor TGTX has paid dividends to shareholders.


Tickers have no history of dividend payments

Financials

ASM vs. TGTX - Financials Comparison

This section allows you to compare key financial metrics between Avino Silver & Gold Mines Ltd. and TG Therapeutics, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


0.0050.00M100.00M150.00M200.00M20222023202420252026
41.41M
204.92M
(ASM) Total Revenue
(TGTX) Total Revenue
Values in USD except per share items

ASM vs. TGTX - Profitability Comparison

The chart below illustrates the profitability comparison between Avino Silver & Gold Mines Ltd. and TG Therapeutics, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

20.0%40.0%60.0%80.0%100.0%20222023202420252026
61.6%
83.7%
Portfolio components
ASM - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Avino Silver & Gold Mines Ltd. reported a gross profit of 25.51M and revenue of 41.41M. Therefore, the gross margin over that period was 61.6%.

TGTX - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, TG Therapeutics, Inc. reported a gross profit of 171.41M and revenue of 204.92M. Therefore, the gross margin over that period was 83.7%.

ASM - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Avino Silver & Gold Mines Ltd. reported an operating income of 21.76M and revenue of 41.41M, resulting in an operating margin of 52.5%.

TGTX - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, TG Therapeutics, Inc. reported an operating income of 34.80M and revenue of 204.92M, resulting in an operating margin of 17.0%.

ASM - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Avino Silver & Gold Mines Ltd. reported a net income of 15.69M and revenue of 41.41M, resulting in a net margin of 37.9%.

TGTX - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, TG Therapeutics, Inc. reported a net income of 19.78M and revenue of 204.92M, resulting in a net margin of 9.7%.


Frequently Asked Questions


ASM and TGTX have a correlation of 0.19, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

ASM has higher volatility (26.77%) compared to TGTX (15.65%). In terms of maximum drawdown, ASM dropped -94.10% vs TGTX's -99.52%.

ASM currently has the higher Sharpe Ratio (0.89 vs 0.69), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for ASM and TGTX

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer